The Mass Drug Administration campaign for Filaria is scheduled to kick off in the second quarter of 2024, as confirmed by Dr. Annastacia Sampson, the representative from Vector Control Services. For a comprehensive report, please refer to Kerese Gonsalves’ coverage.
